JP2024518011A5 - - Google Patents
Info
- Publication number
- JP2024518011A5 JP2024518011A5 JP2023551146A JP2023551146A JP2024518011A5 JP 2024518011 A5 JP2024518011 A5 JP 2024518011A5 JP 2023551146 A JP2023551146 A JP 2023551146A JP 2023551146 A JP2023551146 A JP 2023551146A JP 2024518011 A5 JP2024518011 A5 JP 2024518011A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163151421P | 2021-02-19 | 2021-02-19 | |
| US63/151,421 | 2021-02-19 | ||
| US202163245181P | 2021-09-16 | 2021-09-16 | |
| US63/245,181 | 2021-09-16 | ||
| PCT/US2022/017177 WO2022178367A2 (en) | 2021-02-19 | 2022-02-21 | Single-chain and multi-chain synthetic antigen receptors for diverse immune cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024518011A JP2024518011A (ja) | 2024-04-24 |
| JPWO2022178367A5 JPWO2022178367A5 (https=) | 2025-04-10 |
| JP2024518011A5 true JP2024518011A5 (https=) | 2025-04-10 |
Family
ID=82932320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023551146A Pending JP2024518011A (ja) | 2021-02-19 | 2022-02-21 | 多様な免疫細胞のための単鎖および多鎖合成抗原受容体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240390496A1 (https=) |
| EP (1) | EP4297769A4 (https=) |
| JP (1) | JP2024518011A (https=) |
| KR (1) | KR20230153529A (https=) |
| AU (1) | AU2022224066A1 (https=) |
| CA (1) | CA3208717A1 (https=) |
| IL (1) | IL305175A (https=) |
| WO (1) | WO2022178367A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202000025SA (en) | 2017-07-14 | 2020-02-27 | Immatics Biotechnologies Gmbh | Improved dual specificity polypeptide molecule |
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| MX2020012927A (es) * | 2018-06-01 | 2021-03-25 | Univ Southern California | Diversos dominios de enlace de antigenos, nuevas plataformas y otras mejoras para terapia celular. |
| AU2020214796A1 (en) | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| CA3174575A1 (en) | 2020-03-02 | 2021-09-10 | The Regents Of The University Of California | Chimeric antigen receptors and related methods and compositions for the treatment of cancer |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
| EP4334361A1 (en) | 2021-05-05 | 2024-03-13 | Immatics Biotechnologies GmbH | Antigen binding proteins specifically binding prame |
| US12162940B2 (en) | 2021-05-05 | 2024-12-10 | Immatics Biotechnologies Gmbh | BMA031 antigen binding polypeptides |
| AR130387A1 (es) * | 2022-09-08 | 2024-12-04 | Hoffmann La Roche | Receptores de linfocitos t recombinantes |
| CN118146393A (zh) * | 2022-11-07 | 2024-06-07 | 武汉波睿达生物科技有限公司 | 一种信号肽序列优化的靶向cd19的嵌合抗原受体及其应用 |
| WO2024102954A1 (en) * | 2022-11-10 | 2024-05-16 | Massachusetts Institute Of Technology | Activation induced clipping system (aics) |
| CN121358761A (zh) * | 2023-01-05 | 2026-01-16 | 安吉勒斯治疗公司 | 用于基因转导及调控合成与免疫受体活性的方法和组合物 |
| SE548109C2 (en) * | 2023-03-28 | 2026-03-30 | Cerimmune Therapeutics Ab | Microglial endocytic receptors for use in the treatment of neurodegenerative disease |
| CA3278900A1 (en) * | 2023-03-31 | 2024-10-03 | AbelZeta Inc. | BISPECIFIC CHIMERIC ANTIGENIC RECEPTORS TARGETING CD20 AND BCMA |
| CN121620592A (zh) * | 2023-05-01 | 2026-03-06 | 西雅图儿童医院d/b/a西雅图儿童研究所 | 表达突变体白细胞介素15的免疫细胞 |
| WO2024238962A1 (en) * | 2023-05-18 | 2024-11-21 | A2 Biotherapeutics, Inc. | Immune cells with paired receptors and uses thereof |
| AU2024316791A1 (en) * | 2023-07-28 | 2026-03-12 | Nkilt Therapeutics, Inc. | Chimeric ilt receptor compositions and methods |
| TW202513594A (zh) * | 2023-09-28 | 2025-04-01 | 沛爾生技醫藥股份有限公司 | 具有自然殺手蛋白30跨膜結構域之核酸分子及包含其的嵌合抗原受體 |
| WO2025193475A1 (en) * | 2024-03-14 | 2025-09-18 | The Regents Of The University Of California | Enhancing immune cell innate and adaptive responses |
| WO2025194049A1 (en) * | 2024-03-15 | 2025-09-18 | Dana-Farber Cancer Institute, Inc. | Engineered immune cells and methods of using the same |
| WO2025235862A1 (en) * | 2024-05-10 | 2025-11-13 | Inndura Therapeutics Inc. | A modified immune cell receptor comprising a target-binding domain and the extracellular domain of cd16a |
| US20260015401A1 (en) * | 2024-07-10 | 2026-01-15 | Angeles Therapeutics, Inc. | Compositions and methods comprising epitopes and polypeptides |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2350415A1 (en) * | 1998-11-18 | 2000-05-25 | Incyte Pharmaceuticals, Inc. | Inflammation-associated genes |
| US20070124833A1 (en) * | 2005-05-10 | 2007-05-31 | Abad Mark S | Genes and uses for plant improvement |
| US9833476B2 (en) * | 2011-08-31 | 2017-12-05 | The Trustees Of Dartmouth College | NKP30 receptor targeted therapeutics |
| KR102437522B1 (ko) * | 2012-05-25 | 2022-08-26 | 셀렉티스 | 면역요법을 위한 동종이형 및 면역억제제 저항성인 ｔ 세포의 조작 방법 |
| US20150017136A1 (en) * | 2013-07-15 | 2015-01-15 | Cellectis | Methods for engineering allogeneic and highly active t cell for immunotherapy |
| CN104769103B (zh) * | 2012-09-04 | 2018-06-08 | 塞勒克提斯公司 | 多链嵌合抗原受体和其用途 |
| WO2014039961A1 (en) * | 2012-09-07 | 2014-03-13 | University Of Miami | Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof |
| MX2015015638A (es) * | 2013-05-13 | 2016-10-28 | Cellectis | Metodos para diseñar celulas t altamente activas para inmunoterapia. |
| PL3546572T3 (pl) * | 2013-05-13 | 2024-07-22 | Cellectis | Chimeryczny receptor antygenowy swoisty względem cd19 i jego zastosowania |
| TWI750110B (zh) * | 2014-07-21 | 2021-12-21 | 瑞士商諾華公司 | 使用人類化抗-ｂｃｍａ嵌合抗原受體治療癌症 |
| IL287051B (en) * | 2015-03-27 | 2022-09-01 | Immunitybio Inc | nk-2 cells and genetically engineered monoclonal antibodies for cancer treatment |
| EP4155411A1 (en) * | 2016-02-23 | 2023-03-29 | Salk Institute for Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| CN110352068A (zh) * | 2016-12-02 | 2019-10-18 | 南加利福尼亚大学 | 合成的免疫受体及其使用方法 |
| CN108728465A (zh) * | 2017-04-14 | 2018-11-02 | 深圳新诺微环生物科技有限公司 | 一种表达靶细胞-效应细胞桥接器的微环dna载体及其制备方法和应用 |
| SG11202008568WA (en) * | 2018-03-09 | 2020-10-29 | Sorrento Therapeutics Inc | Dimeric antigen receptors (dar) |
| WO2020028656A1 (en) * | 2018-08-01 | 2020-02-06 | Nantkwest, Inc. | A quadricistronic system comprising a homing receptor or a cytokine, and chimeric antigen receptor for genetic modification of immunotherapies |
-
2022
- 2022-02-21 AU AU2022224066A patent/AU2022224066A1/en active Pending
- 2022-02-21 WO PCT/US2022/017177 patent/WO2022178367A2/en not_active Ceased
- 2022-02-21 EP EP22757078.5A patent/EP4297769A4/en active Pending
- 2022-02-21 KR KR1020237031803A patent/KR20230153529A/ko active Pending
- 2022-02-21 CA CA3208717A patent/CA3208717A1/en active Pending
- 2022-02-21 JP JP2023551146A patent/JP2024518011A/ja active Pending
- 2022-02-21 IL IL305175A patent/IL305175A/en unknown
- 2022-02-21 US US18/275,957 patent/US20240390496A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2025001979A1 (es) | Métodos y composiciones para la transducción de genes y para controlar la actividad de receptores | |
| BR102022025291A2 (https=) | ||
| BR102023014872A2 (https=) | ||
| BR102023012440A2 (https=) | ||
| BR102023010976A2 (https=) | ||
| BR102023009641A2 (https=) | ||
| BR102023008688A2 (https=) | ||
| BR102023007252A2 (https=) | ||
| BR102023005164A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR102022026909A2 (https=) | ||
| BR202022009269U2 (https=) | ||
| BR202022005961U2 (https=) | ||
| BR202022001779U2 (https=) | ||
| BR202022000931U2 (https=) | ||
| BY13145U (https=) | ||
| BY13159U (https=) | ||
| BY13140U (https=) | ||
| BY13141U (https=) | ||
| BY13166U (https=) | ||
| BY13143U (https=) | ||
| BY13144U (https=) | ||
| BY13168U (https=) | ||
| BY13149U (https=) |